Raymond James Financial Services Advisors’s Galmed Pharmaceuticals GLMD Stock Holding History

Raymond James Financial Services Advisors’s Portfolio GLMD Stock Details GLMD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$11.9K	Hold
2022 Q4	$13.9K	Sell
2022 Q3	$18K	Sell
2022 Q2	$42K	Buy
2022 Q1	$101K	Buy
2021 Q4	$45K	Buy
2021 Q3	$59K	Buy
2021 Q2	$51K	Sell
2021 Q1	$59K	Buy